SCHEMBL760255

SCHEMBL760255

Cc1ccc(N2CCC(CN)(O[Si](C)(C)C)CC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.40
DHFR P00374 2/20 0.37
GAA P10253 3/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
AKR1C3 P42330 1/20 0.36
MAPT P10636 6/20 0.35
NPSR1 Q6W5P4 1/20 0.35
USP2 O75604 1/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
C1S P09871 1/20 0.35
RAD52 P43351 1/20 0.34
TP53 P04637 1/20 0.34
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
MMP14 P50281 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL759553 0.73 ADRB1 (0.40) ADRB1DHFRGAANPC1RAB9A
SCHEMBL760412 0.73 SLC6A2 (0.46) ADRB1DHFRGAANPC1RAB9A
SCHEMBL17543949 0.71 ADRB1 (0.50) ADRB1DHFRGAANPC1RAB9A
SCHEMBL23274946 0.70 OPRL1 (0.50) KMT2AMEN1ALDH1A1
SCHEMBL13809519 0.67 ADRB1 (0.50) ADRB1DHFRGAANPC1RAB9A
SCHEMBL24123778 0.67 ADRB1 (0.50) ADRB1DHFRGAANPC1RAB9A
SCHEMBL7105773 0.67 ADRB1 (0.70) ADRB1DHFRGAANPC1RAB9A
SCHEMBL3414344 0.67 ADRB1 (0.70) ADRB1DHFRGAANPC1RAB9A
SCHEMBL10063748 0.67 ADRB1 (0.70) ADRB1DHFRGAANPC1RAB9A
SCHEMBL12082315 0.67 ADRB1 (0.53) ADRB1DHFRGAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US disclosed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137576-A1 Novel Piperidine Derivative HRH4, HRH3, HRH1 ADRB1 87/4885DHFR 3238/4885GAA 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.